Scholar Rock Holding Corporation Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANAB
|
AnaptysBio, Inc. | $24.00 | $640.07 M | -3.82 | 117 | $17.16 M |
 ARVN
|
Arvinas, Inc. | $25.14 | $1.83 B | -4.41 | 445 | $78.50 M |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $2.51 | $291.95 M | -3.13 | 54 | $0 |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $12.51 | $1.29 B | -7.16 | 85 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.64 | $217.51 M | -3.7 | 54 | $0 |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.44 | $243.38 M | -1.59 | 133 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $2.00 | $151.66 M | -3.17 | 45 | $19.94 M |
 IDYA
|
IDEAYA Biosciences, Inc. | $26.52 | $2.88 B | -19 | 124 | $23.39 M |
 IGMS
|
IGM Biosciences, Inc. | $9.44 | $485.17 M | -1.95 | 198 | $2.13 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 14 | $9.16 M |
 KROS
|
Keros Therapeutics, Inc. | $56.55 | $1.76 B | -9.45 | 160 | $151,000 |
 MGTX
|
MeiraGTx Holdings plc | $6.35 | $306.74 M | -4.01 | 387 | $14.02 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.71 | $652.38 M | -6.03 | 28 | $0 |
 PASG
|
Passage Bio, Inc. | $0.63 | $73.04 M | -0.77 | 58 | $0 |
 PLRX
|
Pliant Therapeutics, Inc. | $13.46 | $672.63 M | -3.9 | 166 | $1.58 M |
 RLAY
|
Relay Therapeutics, Inc. | $4.85 | $1.05 B | -3 | 294 | $25.55 M |
 RNA
|
Avidity Biosciences, Inc. | $45.04 | $2.54 B | -8.99 | 253 | $9.56 M |
 RVMD
|
Revolution Medicines, Inc. | $57.53 | $6.66 B | -10.51 | 490 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.76 | $774.50 M | -6.14 | 110 | $8.78 M |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |